Newsroom

The latest Pharaoh Neuro news​​

October 2026

Conference Attendance
Pharaoh Neuro Heads to CNS 2026 with Three Oral Presentations
Event Details: November 1 to 4, 2026 | Washington, D.C.
Press Release​
FDA Grants Breakthrough Device Designation to Pharaoh Neuro’s Neurapheresis™ CSF Management System
October 28, 2026

July 2026

MASSDEVICE MEDICAL NETWORK | Sean Whooley
HistoSonics CEO Mike Blue joins Pharaoh Neuro board of directors
July 23, 2026​
Note: External article will open in a new window ↗
July 23, 2026​
Press Release
Mike Blue Joins the Board of Directors of Pharaoh Neuro
July 23, 2026

April 2026

Featured Topic
Podcast: New potential treatment for brain bleeds from aneurysms and strokes
April 11, 2026
April 11, 2026
Featured Topic
Podcast: New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup​
April 3, 2026
April 3, 2026

February 2026

February 2026​

MASSDEVICE MEDICAL NETWORK | Sean Whooley
Pharoah Neuro raises $20M, names former Medtronic exec as CEO​
February 20, 2026
Note: External article will open in a new window ↗
February 20, 2026
Press Release​
Pharaoh Neuro Announces Executive Changes And Series A Funding​
February 18, 2026

December 2025​

Featured Topic​
Podcast: CSF Filtration After Subarachnoid Hemorrhage​
December 9, 2025

July 2025

Featured Topic​
PILLAR-XT Trial: Open Access Manuscript Published​
July 31, 2025